Note: Ingredients listed on restricted chemical lists
EC/CAS
265-169-7/64742-65-0
Name of the chemical
Distillates (petroleum), solvent-dewaxed heavy paraffinic
Concentration
70 - 80
EC/CAS
265-101-6
Name of the chemical
Residual oils (petroleum), solvent-refined, if they contain > 3 % w/w DMSO extract
Concentration
25-30
General Information
Version
5.0
Revision date
2022-07-22
Product name
Eni OSO 150
1.2.1 Relevant identified uses
Industrial use,Professional use Industrial/Professional use spec Used in closed systems Wide dispersive use
supplier name
Application Engineering & Product Management (AEPM)
Emergency telephone
+39 0382 24444, (+44) 844 892 0111
Icons in SDS
Company Information
company name
Eni Schmiertechnik GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
SDSInfo@eni.com, technik.wuerzburg@eni.com
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP)]
2.1 Classification of the substance or mixture
Classification
Adverse physicochemical, human health and environmental effects
None to be reported, according to the present EU regulations. For specific information about the toxicological/ecotoxicological properties and classification of this product, see Sect. 11 and/or Sect. 12.
2.2 Label elements
Labelling
Supplemental label elements
EUH210 - Safety data sheet available on request. 2.3. Other hazards (not relevant for classification)
Other hazards which do not result in classification
This product is combustible, but not classified as Flammable. The creation of flammable vapour mixtures takes place at temperatures which are higher than normal ambient levels. In case of contact with eyes, this product may cause irritation. If the product is handled or used at high temperature, contact with hot product or vapours may cause burns. Any substance, in case of accidents involving pressurized circuits and the like, may be accidentally injected under the skin, even without external damage. In such a case, the victim should be brought to an hospital as soon as possible, to get specialized medical treatment. Do not wait for symptoms to develop. A potential risk may arise from the release of hydrogen sulfide, when the product is stored or handled at high temperature. Hydrogen sulfide may accumulate in the tanks or other confined spaces, with danger to the workers that enter the spaces. In these cases overexposure to hydrogen sulfide may cause irritation to airways, nausea, dizziness, loss of consciousness and death. This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Component Distillates (petroleum), solvent-dewaxed heavy This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII paraffinic (64742-65-0) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII This substance does not meet the criteria for classification as PBT or vPvB. The product should be considered prudentially as "Persistent" in the environment, according to the REACH Annex XIII criteria (point 1.1) Residual oils (petroleum,) solvent-refined (64742-01- This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII 4) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII This substance does not meet the criteria for classification as PBT or vPvB. The product should be considered prudentially as "Persistent" in the environment, according to the REACH Annex XIII criteria (point 1.1) Component Distillates (petroleum), solvent-dewaxed heavy The substance is not included in the list established in accordance with Article 59(1) of paraffinic(64742-65-0) REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Residual oils (petroleum,) solvent-refined(64742-01- The substance is not included in the list established in accordance with Article 59(1) of 4) REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605